Platination of telomeric DNA by cisplatin disrupts recognition by TRF2 and TRF1

JBIC Journal of Biological Inorganic Chemistry - 2010
Isabelle Ourliac-Garnier1,2, Anaïs Poulet3,4, Razan Charif5,1, Simon Amiard3, Frédérique Magdinier4, Keyvan Rezaï6, Eric Gilson4, Marie-Josèphe Giraud-Panis4,3, Sophie Bombard1,5
1Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, CNRS-UMR8601, Université Paris Descartes, Paris, France
2Telomeres and Cancer Laboratory, UMR3244, Institut Curie, Paris, France
3Université de Lyon, LJC, USR3010 CNRS, Ecole Normale Supérieure de Lyon, Lyon Cedex, France
4Université de Lyon, LBMC, UMR5239 CNRS, Ecole Normale Supérieure de Lyon, Lyon Cedex, France
5Laboratoire d’homéostasie cellulaire et cancer, INSERM-UMR-S 1007, Université Paris Descartes, Paris, France
6Department of Pharmacology Oncology, Centre René Huguenin, Saint-Cloud, France

Tóm tắt

Telomeres, the nucleoprotein complexes located at the ends of chromosomes, are involved in chromosome protection and genome stability. Telomeric repeat binding factor 1 (TRF1) and telomeric repeat binding factor 2 (TRF2) are the two telomeric proteins that bind to duplex telomeric DNA through interactions between their C-terminal domain and several guanines of the telomeric tract. Since the antitumour drug cisplatin binds preferentially to two adjacent guanines, we have investigated whether cisplatin adducts could affect the binding of TRF1 and TRF2 to telomeric DNA and the property of TRF2 to stimulate telomeric invasion, a process that is thought to participate in the formation of the t-loop. We show that the binding of TRF1 and TRF2 to telomeric sequences selectively modified by one GG chelate of cisplatin is markedly affected by cisplatin but that the effect is more drastic for TRF2 than for TRF1 (3–5-fold more sensitivity for TRF2 than for TRF1). We also report that platinum adducts cause a decrease in TRF2-dependent stimulation of telomeric invasion in vitro. Finally, in accordance with in vitro data, analysis of telomeric composition after cisplatin treatment reveals that 60% of TRF2 dissociate from telomeres.

Từ khóa


Tài liệu tham khảo

Autexier C, Lue NF (2006) Annu Rev Biochem 75:493–517

Chong L, van Steensel B, Broccoli D, Erdjument Bromage H, Hanish J, Tempst P, de Lange T (1995) Science 270:1663–1667

Bilaud T, Brun C, Ancelin K, Koering CE, Laroche T, Gilson E (1997) Nat Genet 17:236–239

Broccoli D, Smogorzewska A, Chong L, de Lange T (1997) Nat Genet 17:231–235

Baumann P, Cech TR (2001) Science 292:1171–1175

De Lange T (2005) Cold Spring Harb Symp Quant Biol 70:197–204

Liu D, O’Connor MS, Qin J, Songyang Z (2004) J Biol Chem 279:51338–51342

Xin H, Liu D, Songyang Z (2008) Genome Biol 9:232

Smogorzewska A, de Lange T (2004) Annu Rev Biochem 73:177–208

Gilson E, Geli V (2007) Nat Rev Mol Cell Biol 8:825–838

van Steensel B, de Lange T (1997) Nature 385:740–743

Loayza D, De Lange T (2003) Nature 423:1013–1018

Ancelin K, Brunori M, Bauwens S, Koering CE, Brun C, Ricoul M, Pommier JP, Sabatier L, Gilson E (2002) Mol Cell Biol 22:3474–3487

Karlseder J, Kachatrian L, Takai H, Mercer K, Hingorani S, Jacks T, de Lange T (2003) Mol Cell Biol 23:6533–6541

Iwano T, Tachibana M, Reth M, Shinkai Y (2004) J Biol Chem 279:1442–1448

van Steensel B, Smogorzewska A, de Lange T (1998) Cell 92:401–413

Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Schaefer MR, Schnapp G, de Lange T (2000) Mol Cell Biol 20:1659–1668

Wang RC, Smogorzewska A, de Lange T (2004) Cell 119:355–368

Munoz P, Blanco R, Blasco MA (2006) Cell Cycle 5:718–721

Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T (1999) Science 283:1321–1325

Karlseder J, Smogorzewska A, de Lange T (2002) Science 295:2446–2449

Munoz P, Blanco R, Flores JM, Blasco MA (2005) Nat Genet 37:1063–1071

Nakanishi K, Kawai T, Kumaki F, Hiroi S, Mukai M, Ikeda E, Koering CE, Gilson E (2003) Clin Cancer Res 9:1105–1111

Blasco MA (2005) Nat Rev Genet 6:611–622

Brunori M, Mathieu N, Ricoul M, Bauwens S, Koering CE, Roborel de Climens A, Belleville A, Wang Q, Puisieux I, Decimo D, Puisieux A, Sabatier L, Gilson E (2006) Oncogene 25:990–997

Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, de Lange T (1999) Cell 97:503–514

Amiard S, Doudeau M, Pinte S, Poulet A, Lenain C, Faivre-Moskalenko C, Angelov D, Hug N, Vindigni A, Bouvet P, Paoletti J, Gilson E, Giraud-Panis MJ (2007) Nat Struct Mol Biol 14:147–154

Bilaud T, Koering CE, Binet Brasselet E, Ancelin K, Pollice A, Gasser SM, Gilson E (1996) Nucleic Acids Res 24:1294–1303

Bianchi A, Smith S, Chong L, Elias P, de Lange T (1997) EMBO J 16:1785–1794

Konig P, Fairall L, Rhodes D (1998) Nucleic Acids Res 26:1731–1740

Bianchi A, Stansel RM, Fairall L, Griffith JD, Rhodes D, de Lange T (1999) EMBO J 18:5735–5744

Court R, Chapman L, Fairall L, Rhodes D (2005) EMBO Rep 6:39–45

Nishikawa T, Nagadoi A, Yoshimura S, Aimoto S, Nishimura Y (1998) Structure 6:1057–1065

Nishikawa T, Okamura H, Nagadoi A, Konig P, Rhodes D, Nishimura Y (2001) Structure 9:1237–1251

Bilbille Y, Paquet F, Meudal H, Giraud-Panis MJ, Lancelot G (2006) C R Chim 9:452–458

Heringova P, Kasparkova J, Brabec V (2009) J Biol Inorg Chem 14:959–968

Tahara H, Shin-Ya K, Seimiya H, Yamada H, Tsuruo T, Ide T (2006) Oncogene 25:1955–1966

Biroccio A, Rizzo A, Elli R, Koering CE, Belleville A, Benassi B, Leonetti C, Stevens MF, D’Incalci M, Zupi G, Gilson E (2006) Eur J Cancer 42:1881–1888

Jamieson ER, Lippard SJ (1999) Chem Rev 99:2467–2498

Wang D, Lippard SJ (2005) Nat Rev Drug Discov 4:307–320

Brabec V, Kasparkova J (2005) Drug Resist Updat 8:131–146

Burstyn JN, Heiger-Bernays WJ, Cohen SM, Lippard SJ (2000) Nucleic Acids Res 28:4237–4243

Ishibashi T, Lippard SJ (1998) Proc Natl Acad Sci USA 95:4219–4223

Zhang RG, Zhang RP, Wang XW, Xie H (2002) Cell Res 12:55–62

Jeyapalan JC, Saretzki G, Leake A, Tilby MJ, von Zglinicki T (2006) Int J Cancer 118:2727–2734

Ourliac-Garnier I, Charif R, Bombard S (2009) In: Hadjiliadis N, Sletten E (eds) Metal complexes–DNA interactions. Wiley–Blackwell, Oxford, pp 209–234

Redon S, Bombard S, Elizondo-Riojas MA, Chottard JC (2003) Nucleic Acids Res 31:1605–1613

Colangelo D, Osella D (2005) Curr Med Chem 12:3091–3102

Gonnet F, Kocher F, Blais JC, Bolbach G, Tabet JC (1996) J Mass Spectrom 31:802–809

Reeder F, Kozelka J, Chottard JC (1996) Inorg Chem 35:1413–1415

Ourliac-Garnier I, Elizondo-Riojas MA, Redon S, Farrell NP, Bombard S (2005) Biochemistry 44:10620–10634

LeRoy AF, Wehling ML, Sponseller HL, Friauf WS, Solomon RE, Dedrick RL, Litterst CL, Gram TE, Guarino AM, Becker DA (1977) Biochem Med 18:184–191

Gomez D, Wenner T, Brassart B, Douarre C, O’Donohue MF, El Khoury V, Shin-Ya K, Morjani H, Trentesaux C, Riou JF (2006) J Biol Chem 38721–38729

Fourrier L, Brooks P, Malinge JM (2003) J Biol Chem 278:21267–21275

Nishikawa T, Okamura H, Nagadoi A, Koig P, Rhodes D, Nishimura Y (2001) Nucleic Acids Res Suppl 273–274

Hanaoka S, Nagadoi A, Nishimura Y (2005) Protein Sci 14:119–130

Takahara PM, Rosenzweig AC, Frederick CA, Lippard SJ (1995) Nature 377:649–652

Gonnet F, Reeder F, Kozelka J, Chottard JC (1996) Inorg Chem 35:1653–1658

Legendre F, Bas V, Kozelka J, Chottard JC (2000) Chem Eur J 6:2002–2010

Opresko PL, Fan J, Danzy S, Wilson DM 3rd, Bohr VA (2005) Nucleic Acids Res 33:1230–1239

Thông tin
Thông tin xuất bản

JBIC Journal of Biological Inorganic Chemistry

Thông tin tác giả